Therefore, to investigate whether CD244 and SHP2 affect COPD through the MAPK and NF-κB signaling pathways, we investigated the phosphorylation status of these pathway components in HBE cells treated with CSE. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.